MicroTransponder®, Inc. is a commercial stage company committed to developing research-based neuroscience solutions. The Company focuses on restoring independence and dignity for people suffering from neurological conditions that impair sensory and motor function. MicroTransponder’s FDA-approved Vivistim® Paired VNS™ System is a first-of-its-kind, clinically proven therapy that generates two to three times more improvement in upper limb function than rehabilitation alone for stroke survivors.
Location: United States, Texas, Austin
Total raised: $199.89M
Investors 2
| Date | Name | Website |
| 05.07.2022 | US Venture... | usvp.com |
| 29.06.2022 | Action Pot... | actionpote... |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 16.03.2025 | Series F | $65M | - |
| 21.09.2022 | Series E | $73M | - |
| 30.06.2022 | Series E | $53M | US Venture... |
| 10.12.2015 | - | $5.5M | - |
| 03.09.2013 | - | $3.39M | - |
Mentions in press and media 22
| Date | Title | Description |
| 12.08.2025 | SetPoint Medical Secures $140M for Groundbreaking RA Therapy | SetPoint Medical gained $140M in new funding for its innovative neuroimmune modulation therapy. The FDA-approved SetPoint System targets moderate-to-severe Rheumatoid Arthritis by stimulating the vagus nerve. This significant investment fue... |
| 11.08.2025 | SetPoint Medical Raises $140M to Support Commercialization of Rheumatoid Arthritis Therapy | What You Should Know: – SetPoint Medical, a company focused on developing innovative therapies for chronic autoimmune diseases secures $140M in private financing. This includes the final $25M tranche of its Series C funding and a substantia... |
| 17.03.2025 | MicroTransponder Secures $65 Million to Revolutionize Stroke Recovery | In the heart of Austin, Texas, a medical device company is making waves. MicroTransponder has just raised $65 million in Series F funding. This investment is a significant step forward in the company’s mission to transform stroke recovery. ... |
| 16.03.2025 | MicroTransponder: $65 Million (Series F) Raised For Enhancing Vivistim Adoption For Chronic Stroke Recovery | MicroTransponder – which is one of the fastest-growing stroke companies – announced it is transforming the stroke continuum of care with its FDA-approved Vivistim Paired VNS System. The company also announced it has raised $75 million led b... |
| 14.03.2025 | The Week’s Biggest Funding Rounds: Flock Raises Big As Investors Swarm To Public Safety | 0 Shares Email Facebook Twitter LinkedIn Want to keep track of the largest startup funding deals in 2025 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board. This is a w... |
| 13.03.2025 | MicroTransponder Raises $65M in Series F Funding | MicroTransponder, an Austin, TX-based medical device company, raised $65M in Series F funding. The round was led by US Venture Partners (USVP) and the syndicate of current investors, Osage University Partners, Action Potential Venture Capit... |
| 23.01.2023 | Startups measuring the brain that you need to know | Companies are using biomarkers to diagnose and treat mental illness and other neurological disorders Mental illness is considered the silent pandemic that's been overlooked since the start of COVID. The World Health Organization found the g... |
| 21.09.2022 | MicroTransponder Closes $73M in Series E Financing | MicroTransponder, an Austin, TX-based company focused on restoring dignity and enhancing daily living for people suffering from neurological conditions that impair sensory and motor function, raised $73M in Series E funding. The round was l... |
| 24.06.2022 | MicroTransponder Raises $53M in Series E | AUSTIN, TX, MicroTransponder closed an oversubscribed $53 million Series E funding round led by US Venture Partners. >> Click here for more funding data on MicroTransponder >> To export MicroTransponder funding data to PDF a... |
| 21.06.2022 | MicroTransponder Raises $53M in Series E Funding | MicroTransponder, an Austin, TX-based medical device company, raised $53M in Series E funding. Backers included US Venture Partners, GPG Ventures, Exceller Hunt Ventures, Osage University Partners, Action Potential Venture Capital and The V... |
Show more